During the past decade, Xijing Hospital of Nephrology conducted 4 clinical trials. In the 10-year time frame, 4 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Xijing Hospital of Nephrology" are "Bleeding" (1 trials), "Continuous Renal Replacement Therapy" (1 trials), "Critically Ill" (1 trials), "Hyperlactatemia" (1 trials) and "Hypernatremia" (1 trials). Many other conditions were trialed in "Xijing Hospital of Nephrology" in a lesser frequency.

Most popular intervention types in "Xijing Hospital of Nephrology" are "Procedure" (2 trials), "Biological" (1 trials), "Drug" (1 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "Control group" (1 trials), "Fecal microbiota transplantation" (1 trials), "No-anticoagulation" (1 trials), "No-anticoagulation CRRT" (1 trials) and "Regional citrate anticoagulation" (1 trials). Other intervention names were less common.

The vast majority of trials in "Xijing Hospital of Nephrology" are 4 trials for "All" genders.

Currently, there are NaN active trials in "Xijing Hospital of Nephrology". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were undefined completed trials in Xijing Hospital of Nephrology, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Xijing Hospital of Nephrology, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 3 trials that are defined as “Not Applicable".